TG Therapeutics
TGTX
#2338
Rank
NZ$14.29 B
Marketcap
NZ$93.38
Share price
0.16%
Change (1 day)
91.76%
Change (1 year)

Earnings for TG Therapeutics (TGTX)

Earnings in 2026 (TTM): NZ$0.25 Billion

According to TG Therapeutics's latest financial reports the company's current earnings are NZ$0.70 Billion. In 2025 the company made an earning of NZ$0.22 Billion, an increase over its 2024 earnings that were of NZ$83.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for TG Therapeutics from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.25 B13.42%
2025 NZ$0.22 B169.57%
2024 NZ$83.69 M93.76%
2023 NZ$43.19 M-113.65%
2022 -NZ$0.32 Billion-45.06%
2021 -NZ$0.58 Billion25.42%
2020 -NZ$0.46 Billion62.93%
2019 -NZ$0.29 Billion-3.34%
2018 -NZ$0.3 Billion46.05%
2017 -NZ$0.2 Billion48.38%
2016 -NZ$0.14 Billion29.09%
2015 -NZ$0.11 Billion12.99%
2014 -NZ$92.28 Million180.92%
2013 -NZ$32.85 Million
2009 -NZ$2.99 Million-59.85%
2008 -NZ$7.43 Million
2006 -NZ$16.83 Million-48.34%
2005 -NZ$32.57 Million215.12%
2004 -NZ$10.34 Million29.1%
2003 -NZ$8.01 Million159.59%
2002 -NZ$3.09 Million
2000 -NZ$5.3 Million12.38%
1999 -NZ$4.72 Million7.69%
1998 -NZ$4.38 Million-49.02%
1997 -NZ$8.58 Million82.14%
1996 -NZ$4.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alkermes
ALKS
NZ$0.39 B 58.22%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Dr. Reddy's Laboratories
RDY
NZ$1.11 B 342.71%๐Ÿ‡ฎ๐Ÿ‡ณ India